[Skip to Content]
[Skip to Content Landing]
Citations 0
Health Agencies Update
January 26, 2005

Sickle-Cell Transfusions

JAMA. 2005;293(4):415. doi:10.1001/jama.293.4.415-b

A trial designed to see whether children with sickle cell anemia at high risk for stroke could safely stop receiving periodic red blood cell transfusions after a minimum of 30 months was halted last month by the National Heart, Lung, and Blood Institute, in Bethesda, Md. Early results from the Stroke Prevention Trial (STOP) 2 trial indicated that stopping transfusions cannot be recommended (http://www.nhlbi.nih.gov).

First Page Preview View Large
First page PDF preview
First page PDF preview